Although desmoid tumors do not metastasize, they can be associated with recurrence rates of up to 77% after surgical ...
About OGSIVEO® (nirogacestat) OGSIVEO ® (nirogacestat) is an oral, selective, small molecule gamma secretase inhibitor approved in the United States and European Union as monotherapy for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback